肝细胞癌的栓塞性和 Ablative 疗法
Mian Khalid1, Alisa Likhitsup2, Neehar D Parikh2
1Division of Gastroenterology, University of Maryland Medical Center, Baltimore, MD, USA.
Clinics in liver disease
|November 28, 2024
概括
切除和栓塞等局域性疗法 (LRT) 是肝细胞癌的关键. 将LRT与全身疗法相结合可能会改善结果,并减少高风险患者的复发.
科学领域:
- 肝胆瘤学 肝胆瘤学
- 干预性放射学是干预性的放射学.
- 医学瘤学 医学瘤学
背景情况:
- 地方区域疗法 (LRT) 是肝细胞癌 (HCC) 的标准治疗方法.
- 常见的LRT包括微波切除,射频切除,跨动脉化学栓塞和90Y跨动脉放射栓塞.
- 虽然有效,但LRT与高治疗后复发率有关.
研究的目的:
- 审查embolic和ablativeLRT在HCC管理中的作用.
- 讨论影响LRT选择的因素.
- 探索系统治疗与LRT结合的潜力.
主要方法:
- 对HCC的LRT当前文献的审查.
- 分析影响治疗选择的因素,包括疾病负担和肝功能.
- 检查关于综合系统和LRT方法的新兴数据.
主要成果:
- 慢慢疗法对治愈,弥合或减缓HCC的治疗是有效的.
- 治疗选择取决于疾病的程度和肝功能.
- 同时或辅助的全身疗法显示出改善HCC控制的前景.
结论:
- 在HCC治疗算法中,LRT仍然至关重要.
- 个性化选择LRT是必不可少的.
- 整合全身疗法与LRT提供了一个有前途的策略,以提高HCC患者的治疗结果.
关键词:
我们的BCLCLC是BCLCLC.在HCC中,HCC是HCC.在MWAWA中,MWAWA就是MWA.在RFA RFA RFA.这是TACE的税率.在TARE中,TARE就是TARE.在 Y9090 里,Y9090 里,Y9090 里.更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.3K
05:31Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
5.5K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K